Most HIV/AIDS drugs will be moved from the specialty tier to the generic or non-preferred brand tiers in the individual plans offered by Aetna and its Coventry subsidiary, beginning June 1.

Humana joins Coventry and Cigna in agreeing to lower cost sharing for HIV drugs in health plans offered in Florida.

HHS statements in a recent proposed rule identifying specific Affordable Care Act plan formulary practices as discriminatory elicit strong debate from insurance regulators, payers, patient advocates and pharma companies.

Cigna agrees to cap cost-sharing for some HIV/AIDS drugs at $200 in its exchange plans in Florida as a result of a consent agreement with state regulators. AIDS activists had filed a complaint with HHS alleging Cigna and three other insurers in the state were discriminating against patients with their high copays for HIV/AIDS drugs.